Bio-implants can be defined as prostheses used to regularize physiological functions. They are made up of biosynthetic materials like collagen, and tissue-engineered products like artificial skin or tissues. Most bioengineered products like cardiac pacemakers and orthopedic artificial implants are also covered under bio-implants, since they are implanted entirely in the patient's body.
Bio-implants are mostly classified at a broader level as:
Biological implants (cell therapy, bioartificial organs and tissue engineering)
Biologised implants (technical implants, biohybrid systems, in vivo cell lining)
Biofunctionalized implants (drug eluting stents, surface functionalized implants)
According to the Centers for Disease Control and Prevention (CDC), there were 40 million people aged 65 and above in the United States in 2010, accounting for 13% of the total population. The older population in 2030 is projected to be twice as large as in 2000, growing from 35 million to 72 million and representing nearly 20% of the total U.S. population. This growth in aging population is expected to push the growth of the dental, reconstructive joint replacement, ophthalmic, and neuromodulation implants markets.
This report describes the growth opportunities in the global bio-implants market. It focuses on the increase in demand for technologically advanced products that may help in faster recovery and better efficacy of physiological body functions.
The global bio-implants market is estimated to be $94.1 billion in 2012 and is poised to grow at a CAGR of 7.3% from 2012 to 2017. Rise in the aging population and increase in incidences of chronic diseases like osteoarthritis, old age-related trauma, cardiovascular diseases, neuropathic disorders (Alzheimer's disease and Parkinson's), and congenital disorders and deformities is expected to trigger the growth of this market.
The major players in this market are Stryker Corporation (U.S.), Synthes (U.S.), Boston Scientific Corporation (U.S.), Biomet, Inc. (U.S.), Smith & Nephew (U.K.), Medtronic (U.S.), St. Jude Medical, Inc. (U.S.), Tornier N.V. (The Netherlands), and others.
Scope of the Report
The global bio-implants market is segmented by types, which include major segments such as orthopedic, cardiovascular, dental, ophthalmic, neurostimulation, and others, and by origin (allograft, autograft, xenograft, and synthetic). Each market is comprehensively analyzed at a granular level by geography (North America, Europe, Asia, and Rest of the World) to provide in-depth information on the global scenario.
Global bio-implants market segmentation
By types
Cardiovascular Implants
Pacing Devices
Cardiac Resynchronization Therapy Devices (CRTs)
Implantable Cardioverter Defibrillators (ICDs)
Implantable Cardiac Pacemakers (ICPs)
Pacing Accessories
Pacing Leads
Pacing Batteries
Stents & Related Implants
Coronary Stents
Drug-Eluting Stents
Bare-Metal Coronary Stents
Bioabsorbable stents
Peripheral Stents
Endovascular Stent-Grafts
Renal & Related Stents
Femoral & Related Stents
Carotid Stents
Stent-related Implants
Synthetic Grafts
Vascular Grafts
Peripheral Grafts
Vena Cava Filters
Structural Cardiac Implants
Heart Valves & Accessories
Tissue Heart Valves
Mechanical Heart Valves
Heart Valve Repair Devices
Ventricular-Assist Devices
Implantable Heart Monitors
Insertable Loop Recorders (ILRs)
Imp